← Leaderboards
Thomas Waldmann
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Interleukin-15”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Larry Arthur$22,562,306
- Douglas F Nixon · J. David Gladstone Institutes$22,465,802
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Guido Silvestri · Emory University$20,413,592
- Jeffrey S Miller · University Of Minnesota$17,768,450
Research focus
Interleukin-15Clinical TrialsMalignant NeoplasmsCytokineT-LymphocyteInterleukin-2MediatingAntibodiesCellsCancer TherapyNatural Killer CellsMonoclonal AntibodiesLaboratoriesProductionInterleukin-15 ReceptorHuman T-Lymphotropic Virus 1Preclinical StudyTranslatingSignal TransductionAdultTumorDoseReceptorCd8b1 Gene
Grant awards (32)
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$1,121,221
ZIB · FY2022 · CA · contact PI
IL-2:IL-15 : implications for cancer therapy$779,153
ZIA · FY2022 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$2,431,199
ZIB · FY2021 · CA · contact PI
IL-2:IL-15 : implications for cancer therapy$1,620,799
ZIA · FY2021 · CA · contact PI
COVID-19 research efforts$450,222
ZIA · FY2021 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$2,383,303
ZIB · FY2020 · CA · contact PI
IL-2:IL-15 : implications for cancer therapy (Investigator -Initiated Project)$1,906,642
ZIA · FY2020 · CA · contact PI
COVID-19 research efforts$476,661
ZIA · FY2020 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$2,760,232
ZIB · FY2019 · CA · contact PI
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine$1,552,630
ZIA · FY2019 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$2,747,943
ZIB · FY2018 · CA · contact PI
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine$1,545,717
ZIA · FY2018 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$2,710,901
ZIB · FY2017 · CA · contact PI
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine$1,524,881
ZIA · FY2017 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$2,612,197
ZIB · FY2016 · CA · contact PI
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine$1,469,361
ZIA · FY2016 · CA · contact PI
IL-2IL-15 cytokine receptor: implications for cancer therapy and vaccine$1,556,553
ZIA · FY2015 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$1,556,553
ZIB · FY2015 · CA · contact PI
LyMB Clinical Trials Team$1,210,652
ZID · FY2015 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$1,651,519
ZIB · FY2014 · CA · contact PI
IL-2IL-15 cytokine receptor: implications for cancer therapy and vaccine$1,651,519
ZIA · FY2014 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$1,939,404
ZIB · FY2013 · CA · contact PI
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design$1,939,404
ZIA · FY2013 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$2,207,796
ZIB · FY2012 · CA · contact PI
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design$2,207,796
ZIA · FY2012 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$1,751,169
ZIB · FY2011 · CA · contact PI
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design$1,751,169
ZIA · FY2011 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$1,614,069
ZIB · FY2010 · CA · contact PI
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design$1,614,069
ZIA · FY2010 · CA · contact PI
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design$1,786,679
ZIA · FY2009 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$1,786,679
ZIB · FY2009 · CA · contact PI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy$1,990,761
Z01 · FY2008 · CA · contact PI